1. Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL. Issue 1 (4th December 2020) Authors: Jaramillo, Sonia; Hennemann, Hannah; Horak, Peter; Teleanu, Veronica; Heilig, Christoph E.; Hutter, Barbara; Stenzinger, Albrecht; Glimm, Hanno; Goeppert, Benjamin; Müller‐Tidow, Carsten; Fröhling, Stefan; Schönland, Stefan; Schlenk, Richard F. Journal: EJHaem Issue: Volume 2:Issue 1(2021) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗